Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04536935 · ClinicalTrials.gov registry record · NA

Mobile Mental Health Apps for Suicide Prevention

A NA study of Depression and Anxiety, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
838
Enrollment target
1
Study location

NCT04536935 is a NA study of Depression and Anxiety that has completed, run by University of Washington. The registered enrollment target is 838 participants, roughly in line with the 785-participant average among 679 other Depression trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04536935, a NA study of Depression and Anxiety, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
838 participants
Enrollment target
1
Study location

Study Summary

Access to mental health care by essential workers and the unemployed during the COVID19 pandemic has been challenging. Usual access to mental health care is limited by social distancing, and for many now unemployed due to closures of businesses, insurance is insufficient to cover the costs of mental health care. For these individuals who are at risk for suicide (isolation, unemployment, financial crisis plus past suicide attempts, significant mental health challenges), access to care is crucial and many maybe turning to online and accessible interventions, such as mental health apps and other online resources. Indeed, organizations such as the VA have already created free access mobile applications for mental health in anticipation of this need. Using Psyberguide, the investigators will identify the top ten free apps that address mental health issues and conduct a nation-wide evaluation of these apps with participants who are essential workers and unemployed with risk for suicide. Participants will first be surveyed about which strategies they have used to manage mental health issues, what apps and online tools they have used, and what usability challenges they have faced. The investigators will then ask a random sample of participant to engage in a randomized trial of these top-rated apps for 4 weeks. Apps will be rated on usability, acceptability, feasibility and effectiveness. Results from this trial will be quickly disseminated through several avenues: (1) the UWAC website and ALACRITY Centers network; (2) through CREATIV Lab's partnership with Mental Health America; (3) through the UW Center for Suicide Prevention and Recovery (CSPAR) and partnerships with other suicide focused organizations including Forefront, the American Foundation for Suicide Prevention, that American Association of Suicidology, the Rocky Mountain MIRECC, and the Defense Suicide Prevention Office and (4) through local partnership with King County and WA state contact tracers.

Interventions

  • BEHAVIORAL Mobile Mental Health App - 1
  • BEHAVIORAL Mobile Mental Health App - 2
  • BEHAVIORAL Mobile Mental Health App - 3
  • BEHAVIORAL Mobile Mental Health App - 4

Study Locations (1)

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 838 participants
Start Date 2020-11-30
Est. Completion 2021-06-20
Phase NA

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT04536935

The ClinicalTrials.gov registry entry for NCT04536935 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 838 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 785-participant average among 679 other Depression trials with a reported enrollment target. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 4 interventions - of which Mobile Mental Health App - 1 is the first listed.

NCT04536935 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT04536935 about?

NCT04536935 is a clinical study titled "Mobile Mental Health Apps for Suicide Prevention". Access to mental health care by essential workers and the unemployed during the COVID19 pandemic has been challenging. Usual access to mental health care is limited by social distancing, and for many now unemployed due to closures of businesses, insurance is insufficient to cover the costs of mental...

What is the current status of trial NCT04536935?

This trial is currently completed. It is a NA study. The enrollment target is 838 participants. The study started on 2020-11-30. Estimated completion is 2021-06-20.

What conditions does trial NCT04536935 study?

This clinical trial studies the following conditions: Depression, Anxiety, Emotional Regulation.

What interventions are being tested in trial NCT04536935?

The interventions under investigation include: Mobile Mental Health App - 1 (BEHAVIORAL), Mobile Mental Health App - 2 (BEHAVIORAL), Mobile Mental Health App - 3 (BEHAVIORAL), Mobile Mental Health App - 4 (BEHAVIORAL).

Who is sponsoring clinical trial NCT04536935?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04536935 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.